| Nome |
# |
|
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer, file e3ad891a-fee4-da0e-e053-3705fe0a2b96
|
1.668
|
|
Liquid biopsies in lung cancer: The new ambrosia of researchers, file e3ad8916-f8a0-da0e-e053-3705fe0a2b96
|
1.513
|
|
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis, file e3ad891c-7bb9-da0e-e053-3705fe0a2b96
|
950
|
|
Dietary restriction: could it be considered as speed bump on tumor progression road?, file e3ad8919-0b8f-da0e-e053-3705fe0a2b96
|
543
|
|
EGFR inhibition in NSCLC: New findings…. and opened questions?, file e3ad891a-e75e-da0e-e053-3705fe0a2b96
|
537
|
|
Cancer and the microbiome: Potential applications as new tumor biomarker, file e3ad891b-d8b8-da0e-e053-3705fe0a2b96
|
490
|
|
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs, file e3ad891b-60d9-da0e-e053-3705fe0a2b96
|
457
|
|
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab, file e3ad891b-14a7-da0e-e053-3705fe0a2b96
|
393
|
|
A headlight on liquid biopsies: a challenging tool for breast cancer management, file e3ad8919-1039-da0e-e053-3705fe0a2b96
|
387
|
|
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions, file e3ad8916-f0ee-da0e-e053-3705fe0a2b96
|
334
|
|
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?, file e3ad8917-5e99-da0e-e053-3705fe0a2b96
|
294
|
|
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines, file e3ad8916-f0de-da0e-e053-3705fe0a2b96
|
285
|
|
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?, file e3ad8918-4793-da0e-e053-3705fe0a2b96
|
284
|
|
Liquid Biopsy in Breast Cancer, file e3ad891b-6794-da0e-e053-3705fe0a2b96
|
280
|
|
Nintedanib in NSCLC: Evidence to date and place in therapy, file e3ad8919-7361-da0e-e053-3705fe0a2b96
|
263
|
|
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?, file e3ad891a-6317-da0e-e053-3705fe0a2b96
|
248
|
|
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC), file e3ad891b-3782-da0e-e053-3705fe0a2b96
|
207
|
|
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice, file e3ad8919-0f17-da0e-e053-3705fe0a2b96
|
205
|
|
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients, file e3ad891e-ce8b-da0e-e053-3705fe0a2b96
|
205
|
|
Immunohistochemical/histochemical double staining method in the study of columnar metaplasia of the oesophagus, file e3ad8916-ae11-da0e-e053-3705fe0a2b96
|
200
|
|
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines, file e3ad891b-2783-da0e-e053-3705fe0a2b96
|
199
|
|
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE, file e3ad8917-0bae-da0e-e053-3705fe0a2b96
|
190
|
|
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians., file e3ad8917-0c84-da0e-e053-3705fe0a2b96
|
190
|
|
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus, file e3ad8919-b53d-da0e-e053-3705fe0a2b96
|
189
|
|
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS?, file e3ad8919-6933-da0e-e053-3705fe0a2b96
|
162
|
|
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis, file e3ad891e-81f0-da0e-e053-3705fe0a2b96
|
162
|
|
null, file e3ad891b-6cb8-da0e-e053-3705fe0a2b96
|
119
|
|
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8919-4bd3-da0e-e053-3705fe0a2b96
|
98
|
|
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes, file e3ad8922-de27-da0e-e053-3705fe0a2b96
|
90
|
|
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4), file e3ad8921-ca15-da0e-e053-3705fe0a2b96
|
72
|
|
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma, file e3ad8926-e916-da0e-e053-3705fe0a2b96
|
55
|
|
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS., file e3ad891b-493b-da0e-e053-3705fe0a2b96
|
51
|
|
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines, file e3ad891b-68c8-da0e-e053-3705fe0a2b96
|
46
|
|
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it, file e3ad891c-eddd-da0e-e053-3705fe0a2b96
|
40
|
|
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers, file e3ad891a-81b7-da0e-e053-3705fe0a2b96
|
33
|
|
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8924-a00f-da0e-e053-3705fe0a2b96
|
18
|
|
null, file e3ad891f-7c6c-da0e-e053-3705fe0a2b96
|
16
|
|
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture., file e3ad891b-86d9-da0e-e053-3705fe0a2b96
|
11
|
|
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION, file e3ad8922-9b7e-da0e-e053-3705fe0a2b96
|
11
|
|
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER, file e3ad8921-5b72-da0e-e053-3705fe0a2b96
|
10
|
|
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells, file e3ad891d-4747-da0e-e053-3705fe0a2b96
|
9
|
|
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls?, file e3ad8919-df5c-da0e-e053-3705fe0a2b96
|
8
|
|
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a
systematic review and meta-analysis, file e3ad8920-1335-da0e-e053-3705fe0a2b96
|
8
|
|
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy, file e3ad891f-c3f0-da0e-e053-3705fe0a2b96
|
7
|
|
LIQUID BIOPSY AS A DYNAMIC TOOL FOR LUNG CANCER MANAGEMENT: A FEASIBILITY STUDY FOR PLASMA-DERIVED EXOSOMAL miRNAs AND CELL-FREE DNA., file e3ad8917-4469-da0e-e053-3705fe0a2b96
|
5
|
|
Liquid Biopsy in Gastrointestinal Stromal Tumor, file e3ad891c-6d78-da0e-e053-3705fe0a2b96
|
5
|
|
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells, file e3ad8923-2e51-da0e-e053-3705fe0a2b96
|
5
|
|
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions, file e3ad891e-4b6b-da0e-e053-3705fe0a2b96
|
3
|
|
Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs), file e55f0e7d-16d9-49e6-a1d9-ad5139a057f0
|
3
|
|
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells, file 38edcfcd-dd80-42d0-9119-1bc8a2406ee3
|
2
|
|
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546], file e3ad8923-ae65-da0e-e053-3705fe0a2b96
|
2
|
|
Liquid Biopsy in Gynecological Cancers, file e3ad891b-2c92-da0e-e053-3705fe0a2b96
|
1
|
|
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects, file e3ad891c-6ab2-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
11.564 |